Download FREE Report Sample
Download Free sampleA bispecific antibody (BsAb), or specific monoclonal antibody (BsMAb) is an artificial protein comprised of fragments from two different antibodies. By virtue of the inclusion of two different antigen binding regions, a bispecific antibody is capable of recognizing and binding to two different antigens, or two different epitope on an antigen.
Bi-Specific Antibodies Therapy Market contains market size and forecasts of Bi-Specific Antibodies Therapy in Global, including the following market information:
Global Bi-Specific Antibodies Therapy Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Bi-Specific Antibodies Therapy market was valued at 3360.6 million in 2021 and is projected to reach US$ 16260 million by 2028, at a CAGR of 25.3% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Fragment-Based Antibodies Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Bi-Specific Antibodies Therapy include Roche, Amgen, Sanofi, Pfizer, Johnson & Johnson, AstraZeneca, AbbVie, Lindis Biotech and MacroGenics, Inc, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Bi-Specific Antibodies Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Bi-Specific Antibodies Therapy Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Bi-Specific Antibodies Therapy Market Segment Percentages, by Type, 2021 (%)
Fragment-Based Antibodies
IgG-Based Antibodies
Global Bi-Specific Antibodies Therapy Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Bi-Specific Antibodies Therapy Market Segment Percentages, by Application, 2021 (%)
Cancer
Haemophilia
Other Non-Cancer Diseases
Global Bi-Specific Antibodies Therapy Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Bi-Specific Antibodies Therapy Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Bi-Specific Antibodies Therapy revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Bi-Specific Antibodies Therapy revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Amgen
Sanofi
Pfizer
Johnson & Johnson
AstraZeneca
AbbVie
Lindis Biotech
MacroGenics, Inc
Genmab
Alphamab Co. Ltd
Akeso, Inc.
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
